SIC
PRCT icon

SJS Investment Consulting’s Procept Biorobotics PRCT Stock Holding History

SJS Investment Consulting’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$655 Buy
29
+17
+142% +$426 ﹤0.01% 2175
2026
Q1 		$301 Buy
+12
New +$338 ﹤0.01% 1894

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SJS Investment Consulting's PRCT Position: Q2 2026 in Review

SJS Investment Consulting increased its Procept Biorobotics (PRCT) stake by 142% in Q2 2026, buying an estimated $426 and bringing the position to 29 shares worth $655. The position accounts for ﹤0.01% of the portfolio, ranked #2175.

SJS Investment Consulting first reported a position in PRCT in Q1 2026 and has held it in 2 quarters since. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • SJS Investment Consulting held 29 shares of Procept Biorobotics worth $655 as of Q2 2026.
  • SJS Investment Consulting bought 17 Procept Biorobotics shares in Q2 2026, an estimated $426.
  • Procept Biorobotics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2175 holding.
  • SJS Investment Consulting first reported a position in Procept Biorobotics in Q1 2026 and has held it in 2 quarters since.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.